Abstract
Glucocorticoids are commonly used in the treatment of patients with thyroid disorders, in particular Graves’ ophthalmopathy. Thyrotoxic hypokalemic periodic paralysis (TPP) is an infrequent but potentially serious condition characterised by recurrent episodes of weakness associated with hypokalemia. We describe the development of acute hypokalemic paralysis in a middle-aged Caucasian man with recently diagnosed thyrotoxicosis and severe, active Graves’ opthalmopathy who developed progressive flaccid paralysis 12 hours following intravenous administration of methylprednisolone. Rechallenge with the same dose after the patient had been rendered euthyroid did not provoke TPP. Clinicians should exercise caution when administering high-dose glucocorticoids during thyrotoxicosis as there is a risk of provoking hypokalemic paralysis in susceptible patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Surks MI, Sievert R, 1995 Drugs and thyroid function. N Engl J Med 333: 1688–1694.
Bartalena L, Baldeschi L, Dickinson AJ, et al, 2008 Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid 18: 333–346.
Perros P, Neoh C, Dickinson J, 2009 Thyroid eye disease. BMJ 338: 645–650.
Kung AW, 2006 Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 91: 2490–2495.
Finsterer J, 2008 Primary periodic paralyses. Acta Neurol Scand 117: 145–158.
Wessel K, Schumm F, Peiffer J, Schlote W, 1985 Hypokalemic periodic paralysis provoked by “Ambene”. Nervenarzt 56: 696–702.
Miyashita Y, Monden T, Yamamoto K, et al, 2006 Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis. Intern Med 45: 11–13.
Liu Z, Braverman LE, Malabanan A, 2006 Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocr Pract 12: 427–431.
Wongraoprasert S, Buranasupkajorn P, Sridama V, Snabboon T, 2009 Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern Med 46: 1431–1433.
Arzel-Hézodea M, McGoeybc S, Sternbergabc D, Vicartabc S, Eymarda B, Fontaine B, 2009 Glucocorticoids may trigger attacks in several types of periodic paralysis. Neuromuscular Disorders 19: 217–219.
Tamez-Pérez HE, Cisneros-Pérez V, Cedillo-Rodríguez JA, et al, 2009 Prevalence of hypokalemia in patients with methylprednisolone pulse therapy. Rev Invest Clin 61: 194–197.
Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R, 1994 Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol (Oxf) 41: 213–216.
Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R, 1991 In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 303: 1096–1099.
Clausen T, 2003 Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83: 1269–1324.
Ryan DP, Dias da Silva MR, Soong TW, 2010 Mutations in Potassium Channel Kir2.6 Cause Susceptibility to Thyrotoxic Hypokalemic Periodic Paralysis. Cell 140: 88–98.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tigas, S., Papachilleos, P., Ligkros, N. et al. Hypokalemic paralysis following administration of intravenous methylprednisolone in a patient with Graves’ thyrotoxicosis and ophthalmopathy. Hormones 10, 313–316 (2011). https://doi.org/10.14310/horm.2002.1323
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1323